Laser microporation: A promising field in transdermal drug delivery

Keywords: laser, microporation, transdermal drug delivery

Abstract

Topical therapy is an expanding field not only in dermatology but also in other fields of medicine. An expanding list of systemic medications have been applied topically in several dermatologic conditions. Drugs applied topically have the advantage of fewer side effects, and bypassing the first-pass effect. Also, painless drug delivery which is especially encouraging in children, makes transdermal drug delivery even more appealing. 

References

Chiu HY, Tsai TF. Topical use of systemic drugs in dermatology: A comprehensive review. J Am Acad Dermatol 2011; 65(5): 1048.e1–1048.e22. doi: 10.1016/j.jaad.20 10.08.034.

Zech NH, Murtinger M, Uher P. Pregnancy after ovarian superovulation by transdermal delivery of follicle-stimulating hormone. Fertil Steril 2011; 95(8): 2784–2785. doi: 10.1016/j.fertnstert.2011.03.073.

Subramony JA. Needle free parenteral drug delivery: Leveraging active transdermal technologies for pediatric use. Int J Pharm 2013; 455(1–2): 14–18. doi: 10.1016/j.ijpharm.2013.07.055.

Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Delivery 2009; 6(4): 343–354. doi: 10.1517/17425240902841935.

Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Delivery 2008; 5(11): 1267–1282. doi: 10.1517/17425240802497218.

Singh MD, Mital N, Kaur G. Topical drug delivery systems: A patent review. Expert Opin Ther Pat 2016; 26(2): 213–228. doi: 10.1517/13543776.2016.1131267.

Microporation techniques for enhanced delivery of ther-apeutic agents. Recent Pat Drug Delivery Formulation 2010; 4(1): 1–17. doi: 10.2174/187 221110789957174.

Scheiblhofer S, Thalhamer J, Weiss R. Laser microporation of the skin: Prospects for painless application of protective and therapeutic vaccines. Expert Opin Drug Delivery

; 10(6): 761–773. doi: 10.1517/17 425247.2013.773970.

Chen X, Shah D, Kositratna G, Manstein D, Anderson RR, et al. Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Controlled Release. 2012; 159(1): 43–51. doi: 10.10 16/j.jconrel.2012.01.002.

Hsiao CY, Sung HC, Hu S, Huang CH. Fractional CO2 laser treatment to enhance skin permeation of tranexamic acid with minimal skin disruption. Dermatology 2015; 230(3): 269–75. doi: 10.1159/000371386.

Oni G, Rasko Y, Kenkel J. Topical lidocaine enhanced by laser pretreatment: A safe and effective method of analgesia for facial rejuvenation. Aesthetic Surg J 2013; 33(6): 854–861. doi: 10.1177/1090820X13496248.

Cunha PR, Scabine Pessotti N, Bonati Mattos C, Salai AF. New approach in the treatment of refractory vitiligo: CO2 laser combined with betamethasone and salicylic acid solution. Dermatol Ther 2017; 30: e12410. doi: 10.1111/dth.12410.

Park JH, Chun JY, Lee JH. Laser-assisted topical corticosteroid delivery for the treatment of keloids. Lasers Med Sci 2017; doi: 10.1007/s10103-017-2154-5.

Riggs K, Keller M, Humphreys TR. Ablative laser resurfacing: High-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. Clin Dermatol 2007; 25(5): 462–473. doi: 10.1016/j.clindermatol.2007.07.003

Zaleski-Larsen LA, Fabi SG. Laser-assisted drug delivery. Dermatol Surg. 2016; 42(8): 919–931. doi: 10.1097/DSS.0000000000000556

Published
2021-09-25
Section
Short Communications